Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 mars 2011 06h30 HE | Source: QLT Inc.

QLT Announces Fourth Quarter and Year End 2010 Results

VANCOUVER, British Columbia, March 1, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the fourth quarter ended December 31,...
23 févr. 2011 06h30 HE | Source: QLT Inc.

QLT Chief Medical Officer Steps Down

VANCOUVER, British Columbia, Feb. 23, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced the departure of Dipak Panigrahi, MD, Senior Vice President,...
10 févr. 2011 06h30 HE | Source: QLT Inc.

QLT Receives Positive Opinions for Orphan Drug Designation by the European Medicines Agency for QLT091001 to Treat Two Hereditary Blindness Diseases

VANCOUVER, British Columbia, Feb. 10, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that QLT091001, an oral synthetic retinoid, has received...
09 févr. 2011 06h30 HE | Source: QLT Inc.

QLT Announces Phase II Clinical Trial Results for the Olopatadine Punctal Plug Delivery System (O-PPDS)

VANCOUVER, British Columbia, Feb. 9, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced results from a Phase II proof-of-concept clinical trial for the...
10 déc. 2010 06h30 HE | Source: QLT Inc.

QLT Announces Toronto Stock Exchange Approval of Share Repurchase Program

VANCOUVER, British Columbia, Dec. 10, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that the Toronto Stock Exchange ("TSX") has accepted the notice...
08 déc. 2010 06h30 HE | Source: QLT Inc.

QLT Announces Share Repurchase Program

VANCOUVER, British Columbia, Dec. 8, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that its board of directors has approved the repurchase of up to...
07 déc. 2010 16h02 HE | Source: QLT Inc.

QLT Receives Orphan Drug Designation for QLT091001 to Treat Retinitis Pigmentosa

VANCOUVER, British Columbia, Dec. 7, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that QLT091001, the Company's oral synthetic retinoid, has been...
07 déc. 2010 16h01 HE | Source: QLT Inc.

QLT Receives Orphan Drug Designation for QLT091001 to Treat Leber Congenital Amaurosis

VANCOUVER, British Columbia, Dec. 7, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has granted...
29 nov. 2010 06h30 HE | Source: QLT Inc.

QLT Ophthalmics, Inc. Establishes an Activis PDT Laser Co-Promotion Agreement With Quantel Medical and Quantel USA in the United States

VANCOUVER, British Columbia, Nov. 29, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced that its wholly-owned U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"), and Quantel...
03 nov. 2010 06h30 HE | Source: QLT Inc.

QLT Announces Third Quarter Results for 2010

VANCOUVER, British Columbia, Nov. 3, 2010 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today reported financial results for the third quarter ended September 30, 2010....

Page précédente

Page suivante